Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group
Open Access
- 25 September 2012
- journal article
- research article
- Published by Wiley in International Journal of Molecular Imaging
- Vol. 2012, 1-8
Abstract
Purpose. 123I-metaiodobenzylguanidine (MIBG) is used for the diagnostic evaluation of neuroblastoma. We evaluated the relationship between norepinephrine transporter (NET) expression and clinical MIBG uptake. Methods. Quantitative reverse transcription PCR () and immunohistochemistry (IHC; ) were performed for neuroblastoma NET mRNA and protein expression and correlated with MIBG avidity on diagnostic scans. The correlation of NET expression with clinical features was also performed. Results. Median NET mRNA expression level for the 19 MIBG avid patients was 12.9% (range 1.6–73.7%) versus 5.9% (range 0.6–110.0%) for the 8 nonavid patients (). Median percent NET protein expression was 50% (range 0–100%) in MIBG avid patients compared to 10% (range 0–80%) in nonavid patients (). MYCN amplified tumors had lower NET protein expression compared to nonamplified tumors (10% versus 50%; ). Conclusions. NET protein expression in neuroblastoma correlates with MIBG avidity. MYCN amplified tumors have lower NET protein expression.
Keywords
Funding Information
- Campini Foundation (UL1 RR024131, U10 CA98413, U10 CA98543)
- Dougherty Foundation (UL1 RR024131, U10 CA98413, U10 CA98543)
- Alex’s Lemonade Stand Foundation (UL1 RR024131, U10 CA98413, U10 CA98543)
- National Institutes of Health (UL1 RR024131, U10 CA98413, U10 CA98543)
- National Institutes of Health (UL1 RR024131, U10 CA98413, U10 CA98543)
- National Institutes of Health (UL1 RR024131, U10 CA98413, U10 CA98543)
This publication has 29 references indexed in Scilit:
- Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model SystemsClinical Cancer Research, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- Outcome after Reduced Chemotherapy for Intermediate-Risk NeuroblastomaNew England Journal of Medicine, 2010
- Adrenergic Excess, hNET1 Down-Regulation, and Compromised mIBG Uptake in Heart FailureJACC: Cardiovascular Imaging, 2010
- Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cellsNuclear Medicine and Biology, 2009
- Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaNuclear Medicine and Biology, 2008
- Chromosome 6p22 Locus Associated with Clinically Aggressive NeuroblastomaNew England Journal of Medicine, 2008
- Application of Targeted Radiotherapy/Gene Therapy to Bladder Cancer Cell LinesEuropean Urology, 2005
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003
- Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: Correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expressionEuropean Journal of Cancer, 1995